Teresa Etter, APRN
Critical Care Medicine · Enid, OKNPI 1598096646
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,908 of the $4,775 with a category attached, or 60.9%. 17 manufacturers reported payments, led by Abbott at 29.6% of the total. 2025 is the largest year on record at $1,520, 2.4 times the $626 reported in 2022. Among critical care medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $54.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Relievant Medsystems, Inc.$1K
- Boston Scientific$1K
- AbbVie$149
- Saluda Medical Americas, Inc.$81
- SPR Therapeutics, Inc$71
- plus $292 from 11 others
What the payments were for
- Travel & lodging$2,90861%
- Food & beverage$1,86839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 28 | $1,412 |
| Relievant Medsystems, Inc. | 8 | $1,411 |
| Boston Scientific | 19 | $1,358 |
| AbbVie | 9 | $149 |
| Saluda Medical Americas, Inc. | 5 | $81 |
| SPR Therapeutics, Inc | 2 | $71 |
| Vertos Medical, Inc. | 1 | $42 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| Medtronic | 2 | $33 |
| Convatec Inc. | 1 | $29 |
| Amgen | 2 | $29 |
| Averitas Pharma Inc. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Si-bone, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Vertex | 1 | $16 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,775 in reported general payments places this provider in the 90th percentile of 57 critical care medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 13 | $14,116 |
| MovantikNaloxegol Oxalate | 30 | $11,615 |
| Gabapentin | 208 | $4,074 |
| Tizanidine Hcl | 107 | $1,518 |
| Lidocaine | 14 | $1,212 |
| Baclofen | 61 | $914 |
| Cyclobenzaprine Hcl | 40 | $817 |
| Duloxetine Hcl | 33 | $791 |
| Celecoxib | 26 | $620 |
| Amitriptyline Hcl | 19 | $528 |
| Methocarbamol | 40 | $357 |
| Ibuprofen | 11 | $289 |
| Meloxicam | 16 | $164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $149 | $14,11613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 57 critical care medicine providers in Oklahoma.
Other critical care medicine in Enid
- Obaid AshrafOklahoma City$12K
- Joseph RawdonShawnee$9K
- Daniel HopkinsTulsa$7K
- Michael HarperOklahoma City$6K
- Syed AnwerOklahoma City$4K
- Brooke WeaverTulsa$4K
- Victoria KyleOklahoma City$4K
- Himanshu BhardwajOklahoma City$3K
- Mark RolfeOklahoma City$3K
- Sanchit ChawlaTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.